Brazil’s Senate Social Affairs Committee has approved a measure to include the shingles vaccine in the country’s public health system, known as the SUS. The decision, reported by Senado Federal on Tuesday, moves the proposal one step closer to offering the shot free of charge to eligible citizens.
The committee’s approval means the vaccine against herpes-zoster, the virus that causes shingles, will now advance through the legislative process. According to Senado Federal, the measure aims to expand access to the immunization, which is currently available mainly through private clinics at significant cost to patients.
Shingles is a painful condition caused by the reactivation of the chickenpox virus, which remains dormant in the body after an initial infection. The vaccine works by boosting the immune system’s response to that virus, reducing the risk of both the disease and its complications. Senado Federal reports that the proposal specifies which groups would be prioritized for the free shots, though full eligibility details are still pending final approval.
The move comes amid growing evidence of broader benefits from the vaccine. A separate report cited by folhape.com.br links the shingles shot to a lower risk of cardiovascular diseases, adding weight to arguments for wider public access. Terra has also published explanatory material on how the vaccine works and who should consider taking it.
The proposal still requires further votes before it becomes law. Observers will watch the next Senate session to see whether the full chamber backs the committee’s decision and how quickly the Health Ministry could implement distribution once approved.
